Xenon Pharmaceuticals IncNASDAQ:XENE
- LAST PRICE38.2400
- TODAY'S CHANGE (%)0.5600 (1.4862%)
- Bid / Lots38.2500/ 1
- Ask / Lots40.4900/ 1
- Open / Previous Close37.5000 / 37.6800
- Day Range
- 52 Week Range
- Volume195,021
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | XENE |
|---|---|---|
| 09:32 ET | 806 | 37.5 |
| 09:36 ET | 3561 | 37.66 |
| 09:43 ET | 100 | 37.395 |
| 09:45 ET | 100 | 37.395 |
| 09:52 ET | 626 | 37.57 |
| 09:54 ET | 6115 | 37.36 |
| 09:56 ET | 100 | 37.36 |
| 10:01 ET | 428 | 37.61 |
| 10:06 ET | 182 | 37.68 |
| 10:08 ET | 500 | 37.62 |
| 10:12 ET | 1200 | 37.43 |
| 10:14 ET | 1100 | 37.45 |
| 10:15 ET | 200 | 37.38 |
| 10:19 ET | 100 | 37.46 |
| 10:21 ET | 300 | 37.55 |
| 10:33 ET | 100 | 37.72 |
| 10:35 ET | 100 | 37.77 |
| 10:37 ET | 100 | 37.775 |
| 10:39 ET | 100 | 37.795 |
| 10:44 ET | 302 | 37.76 |
| 10:46 ET | 200 | 37.77 |
| 10:50 ET | 100 | 37.85 |
| 10:51 ET | 255 | 37.88 |
| 10:53 ET | 600 | 37.775 |
| 10:55 ET | 100 | 37.8 |
| 10:57 ET | 200 | 37.865 |
| 11:00 ET | 100 | 37.87 |
| 11:02 ET | 400 | 37.945 |
| 11:04 ET | 1720 | 38.05 |
| 11:06 ET | 300 | 38.01 |
| 11:08 ET | 100 | 37.96 |
| 11:22 ET | 256 | 38.0667 |
| 11:27 ET | 400 | 38.2 |
| 11:31 ET | 100 | 38.195 |
| 11:33 ET | 146 | 38.2307 |
| 11:44 ET | 100 | 38.16 |
| 11:49 ET | 600 | 38.21 |
| 11:51 ET | 317 | 38.215 |
| 11:54 ET | 2400 | 38.25 |
| 11:58 ET | 600 | 38.22 |
| 12:00 ET | 300 | 38.07 |
| 12:07 ET | 400 | 38.055 |
| 12:09 ET | 200 | 38 |
| 12:20 ET | 100 | 38.025 |
| 12:21 ET | 100 | 38.025 |
| 12:25 ET | 700 | 38.03 |
| 12:38 ET | 100 | 38.02 |
| 12:39 ET | 100 | 37.98 |
| 12:45 ET | 100 | 38.03 |
| 12:50 ET | 409 | 37.91 |
| 12:54 ET | 100 | 37.975 |
| 12:56 ET | 200 | 37.9 |
| 12:57 ET | 100 | 37.81 |
| 12:59 ET | 100 | 37.86 |
| 01:01 ET | 495 | 37.89 |
| 01:03 ET | 1524 | 37.85 |
| 01:08 ET | 100 | 37.84 |
| 01:10 ET | 537 | 37.78 |
| 01:14 ET | 100 | 37.76 |
| 01:15 ET | 117 | 37.765 |
| 01:28 ET | 100 | 37.78 |
| 01:30 ET | 200 | 37.745 |
| 01:35 ET | 400 | 37.72 |
| 01:37 ET | 2800 | 37.86 |
| 01:39 ET | 100 | 37.885 |
| 01:42 ET | 400 | 37.93 |
| 01:46 ET | 1846 | 38.031 |
| 01:50 ET | 200 | 37.975 |
| 01:53 ET | 200 | 37.9 |
| 01:55 ET | 100 | 37.975 |
| 02:06 ET | 234 | 38.03 |
| 02:09 ET | 300 | 37.985 |
| 02:11 ET | 438 | 37.945 |
| 02:13 ET | 100 | 37.95 |
| 02:22 ET | 200 | 37.92 |
| 02:24 ET | 300 | 37.875 |
| 02:26 ET | 200 | 37.855 |
| 02:27 ET | 200 | 37.87 |
| 02:29 ET | 200 | 37.88 |
| 02:31 ET | 614 | 37.94 |
| 02:33 ET | 200 | 37.96 |
| 02:38 ET | 100 | 38.01 |
| 02:40 ET | 600 | 38.035 |
| 02:44 ET | 400 | 38.15 |
| 02:45 ET | 400 | 38.14 |
| 02:47 ET | 300 | 38.16 |
| 02:49 ET | 100 | 38.17 |
| 02:51 ET | 300 | 38.18 |
| 02:54 ET | 500 | 38.19 |
| 02:56 ET | 200 | 38.22 |
| 02:58 ET | 200 | 38.21 |
| 03:03 ET | 300 | 38.08 |
| 03:05 ET | 260 | 38.124 |
| 03:09 ET | 100 | 38.115 |
| 03:14 ET | 500 | 38.14 |
| 03:16 ET | 200 | 38.145 |
| 03:18 ET | 300 | 38.19 |
| 03:20 ET | 392 | 38.19 |
| 03:21 ET | 1232 | 38.11 |
| 03:23 ET | 300 | 38.17 |
| 03:25 ET | 300 | 38.19 |
| 03:27 ET | 300 | 38.19 |
| 03:30 ET | 1400 | 38.065 |
| 03:32 ET | 713 | 38.12 |
| 03:34 ET | 400 | 38.15 |
| 03:36 ET | 100 | 38.16 |
| 03:38 ET | 2100 | 38.16 |
| 03:39 ET | 718 | 38.23 |
| 03:41 ET | 200 | 38.22 |
| 03:43 ET | 500 | 38.21 |
| 03:45 ET | 341 | 38.24 |
| 03:48 ET | 1400 | 38.25 |
| 03:50 ET | 100 | 38.25 |
| 03:52 ET | 1220 | 38.15 |
| 03:54 ET | 2359 | 38.17 |
| 03:56 ET | 3089 | 38.13 |
| 03:57 ET | 4300 | 38.15 |
| 03:59 ET | 12944 | 38.24 |
Jun 5, 2024
Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference, from 4:01PM ET on Wednesday Jun 05, 2024 by Dow Jones
4:01PM ET on Wednesday Jun 05, 2024 by Dow Jones
May 28, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Xenon Pharmaceuticals Inc | 2.9B | -14.1x | --- |
MoonLake Immunotherapeutics | 2.7B | -55.9x | --- |
SpringWorks Therapeutics Inc | 3.0B | -7.8x | --- |
Biohaven Ltd | 3.1B | -5.1x | --- |
Structure Therapeutics Inc | 2.6B | -22.8x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Company Information
Xenon Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company’s product pipeline includes XEN1101 (Focal Onset Seizures), XEN1101 (Primary Generalized Tonic-Clonic Seizures), XEN1101 (Major Depressive Disorder) and NBI-921352 (NEUROCRINE). It is developing XEN1101, a differentiated Kv7 potassium channel opener, for the treatment of epilepsy, MDD and potentially other neurological disorders. Its XEN1101 Phase III epilepsy program includes two identical Phase III clinical trials, called X-TOLE2 and X-TOLE3, that are designed closely after the Phase IIb X-TOLE clinical trial. Its Phase III X-ACKT clinical trial is intended to support potential regulatory submissions in an additional epilepsy indication of primary generalized tonic-clonic seizures (PGTCS).
Contact Information
- Headquarters
- 3650 Gilmore WayVANCOUVER, BC, Canada V5G 4W8
- Phone
- 604-484-3300
- Fax
- 604-484-3450
Executives
- Chairman of the Board
- Simon Pimstone
- President, Chief Executive Officer, Director
- Ian Mortimer
- Chief Financial Officer
- Sherry Aulin
- Executive Vice President - Drug Discovery
- James Empfield
- Executive Vice President - Strategy and Innovation
- Robin Sherrington
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.9B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 75.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.27 |
EPS | $-2.71 |
Book Value | $12.31 |
P/E Ratio | -14.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
